Veracyte, Inc. (VCYT)
NASDAQ: VCYT · Real-Time Price · USD
29.77
-0.35 (-1.16%)
Mar 31, 2025, 10:15 AM EDT - Market open
Veracyte Market Cap
Veracyte has a market cap or net worth of $2.32 billion as of March 31, 2025. Its market cap has increased by 40.06% in one year.
Market Cap
2.32B
Enterprise Value
2.11B
1-Year Change
40.06%
Ranking
Category
Stock Price
$29.77
Market Cap Chart
Since October 30, 2013, Veracyte's market cap has increased from $274.10M to $2.32B, an increase of 746.56%. That is a compound annual growth rate of 20.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 2.35B | -23.50% |
| Dec 31, 2024 | 3.07B | 52.74% |
| Dec 29, 2023 | 2.01B | 18.01% |
| Dec 30, 2022 | 1.70B | -41.83% |
| Dec 31, 2021 | 2.93B | 3.30% |
| Dec 31, 2020 | 2.83B | 107.80% |
| Dec 31, 2019 | 1.36B | 167.37% |
| Dec 31, 2018 | 510.00M | 129.42% |
| Dec 29, 2017 | 222.30M | 2.77% |
| Dec 30, 2016 | 216.30M | 8.58% |
| Dec 31, 2015 | 199.20M | -8.37% |
| Dec 31, 2014 | 217.40M | -28.72% |
| Dec 31, 2013 | 305.00M | 11.27% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |